Scynexis

Trending Articles

  1. Merck's MilliporeSigma cuts the ribbon on €290m US biosafety and analytical facility The site will host biosafety testing, analytical development and cell banking manufacturing services
  2. Johnson & Johnson completes V-Wave acquisition to support patients with heart failure The strategic acquisition will bolster the pharma giant's MedTech offerings for patients with cardiovascular disease
  3. Calluna Pharma appoints Mark Gaffney as CEO and Mark Altmeyer as Chair of the Board The two will work to advance the company's global presence, while developing its lead programme
  4. ABITEC Corporation bolsters its high-purity lipid offerings for LNP therapeutics The company can provide cGMP-grade lipids from a mg to a kg scale, assisting the production of advanced LNP therapeutics, including vaccines
  5. Roche's breast cancer combination therapy Itovebi bags FDA approval Itovebi plus palbociclib and fulvestrant reduced the risk of disease progression or death significantly in patients

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Research & Development

Cypralis to acquire Scynexis assets

The deal includes a large portfolio of cyclophilin inhibitors
Research & Development

Dennis Schmatz joins Scynexis

Will provide advice to US firm as it advances drug development programme
Sustainability

Scynexis extends sleeping sickness collaboration to 2012

Extends collaboration with the Drugs for Neglected Diseases initiative (DNDi)
Subscribe now